Corrigendum to 'Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study': [ESMO Open Volume 5, Issue 6, 2020, e000985]

ESMO Open. 2021 Feb;6(1):100052. doi: 10.1016/j.esmoop.2021.100052. Epub 2021 Jan 23.

L Shi¹, C Xu², Y Ma³, Q Ou³, X Wu³, S Lu⁴, Y Shao⁵, R Guo⁶, J Kong⁷

¹ Department of Thoracic Oncology, Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
² Department of Oncology, First Affiliated Hospital of Soochow University, Suzhou, China.
³ Translational Medicine Research Institute, Geneseeq Technology Inc, Toronto, Ontario, Canada.
⁴ Pulmonary and Critical Care Medicine Ward, Guangxi Medical University First Affiliated Hospital, Nanning, China.
⁵ Research and Development, Nanjing Geneseeq Technology Inc, Nanjing, China; School of Public Health, Nanjing Medical University, Nanjing, China.
⁶ Department of Medical Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Electronic address: guorenhua@csco.ac.cn.
⁷ Pulmonary and Critical Care Medicine Ward, Guangxi Medical University First Affiliated Hospital, Nanning, China. Electronic address: kjl071@163.com.

No abstract available

Publication types